Evaluation of the safety and efficacy of gadoteridol injection (a low osmolal magnetic resonance contrast agent). Clinical trials report.
DeSimone
D
D
Squibb Diagnostics, Princeton, New Jersey.
Morris
M
M
Rhoda
C
C
Lucas
T
T
Zielonka
J
J
Olukotun
A
A
Carvlin
M
M
D000328:Adult; D001932:Brain Neoplasms / Q000175:diagnosis; D003287:Contrast Media / Q000008:administration & dosage / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005682:Gadolinium / Q000008:administration & dosage / Q000009:adverse effects*; D006571:Heterocyclic Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007275:Injections, Intravenous; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D009994:Osmolar Concentration; D013125:Spinal Neoplasms / Q000175:diagnosis
D003287:Contrast Media; D006571:Heterocyclic Compounds; D009942:Organometallic Compounds; C062402:gadoteridol; D005682:Gadolinium